A General Study on Corona Virus and Highlighting the Rehabilitation of the Respiratory System in Elderly Patients Infected with Corona Virus in Thi-Qar
Main Article Content
Abstract
Coronavirus (COVID-19) is a respiratory virus that emerged at the end of 2019 in Wuhan, Hubei Province, China. The virus has rapidly spread worldwide and has been classified by the World Health Organization as a global pandemic. Common symptoms of coronavirus infection include fever, dry cough, and difficulty breathing. Some may experience sore throat, fatigue, muscle aches, and loss of sense of smell or taste. Symptoms can appear within 2-14 days of exposure to the virus.
Prevention of Coronavirus includes following important health measures such as washing hands regularly for at least 20 seconds with soap and water, avoiding touching the face with unsanitized hands, wearing protective masks in public places, practicing social distancing by staying away from crowds, and regularly cleaning and sterilizing contact surfaces.
There is no specific treatment for Coronavirus yet. Symptoms are treated individually, such as taking medications to reduce fever, relieve pain, and going to rest and recuperation. If symptoms worsen or difficulty breathing occurs, you should contact the competent medical staff to obtain the necessary medical assistance.
Effective coronavirus vaccines have been developed and widely distributed. It is recommended to take the vaccine for effective protection against the virus and reduce the chances of developing serious symptoms.
It is recommended to follow official and reliable sources to obtain the latest developments and guidance regarding the Coronavirus, such as The World Health Organization and the country's health organization are working to address the situation effectively.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. M.A. Shereen, S. Khan, A. Kazmi, N. Bashir, R. Siddique, COVID-19 infection: origin, transmission, and characteristics of human, J. Adv. Res. (2020) 91–98.
II. C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet (2020) 497–506.
III. S. Chavez, B. Long, A. Koyfman, S.Y. Liang, Coronavirus Disease (COVID-19): a primer for emergency physicians, AJEM (Am. J. Emerg. Med.) (2020) 1–10.
IV. C. Huang et al., 2020; Zhou et al., 2020b; Zhu et al., 2020.
V. Chan et al., 2020: JHU, 2020; M, 2020; Nature, 2020b; Reuters, 2020a; Reuters, 2020b JHU, 2020; M, 2020; Nature, 2020b; Reuters, 2020a; Reuters, 2020b; Rothe et al., 2020; S, 2020 .
VI. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descript- tive study. Lancet. 2020; 395 (10223), 507-13.
VII. Huang C, Wang Y, Li X, et al. Clinical features of pa- tients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223), 497-506.
VIII. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lan- cet. 2020; 395 (10229), 1054-62.
IX. Lamba, American Journal of Emergency Medicine Volume 38, Issue 7, July 2020, Pages 1528-1529.
X. S. Chavez, B. Long, A. Koyfman, S.Y. Liang, Coronavirus Disease (COVID-19): a primer for emergency physicians, AJEM (Am. J. Emerg. Med.) (2020) 1–10
XI. T. Singhal, A review of coronavirus disease-2019 (COVID-19), Indian J. Pediatr. (2020) 281-286.
XII. Ahmada F., Ahmeda., A, Rajendraprasada S.S., Lorangera F., Guptaa S., Velagapudia M…Moore D. (2021). Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection. International Journal of Infectious Diseases, 2021-07-01, Volume 108, Pages 209-211.
XIII. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-1844. doi:10.1001/jama. 2020.3786.
XIV. Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a non-invasive specimen for detection of SARS-CoV-2.J Clin Microbiol. Published online April 21, 2020. doi:10.1128/JCM.00776-20.
XV. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. Published online March 28, 2020. doi:10.1093/cid/ciaa344.
XVI. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-434.
XVII. Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T,Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845-1854.
XVIII. Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005;60:401-409.
XIX. Huang Z, Wang NH, Lan Y, Li M, Chen R. Rehabilitation for the patients with severe acute respiratory syndrome in remission (in Chinese). Chin J Rehabil Med .2004;10:15-17.
XX. L.-L. Yang, T. Yang / Chronic Diseases and Translational Medicine 6 (2020) 79-86